BrainStorm Cell Therapeutics

Israel

BrainStorm Cell Therapeutics Inc.
110 East 59th Street
New York NY 10022
Tel: (212)-557-9000
Fax: (212)-581-8958
E-mail: info@brainstorm-cell.com

BrainStorm Cell Therapeutics Ltd.
12 Bazel St., POB 10019 Kiryat Aryeh,
Petach Tikva, Israel 49001
Tel: (972) 3.923.6384
Fax: (972) 3.923.6385
E-mail: info@brainstorm-cell.com
www.brainstorm-cell.com

About BrainStorm Cell Therapeutics

BrainStorm is an Israeli company that develops stem cell technology to provide solutions for incurable diseases, such Parkinson's disease, amyotrophic lateral sclerosis, and spinal cord injury. The company is focused on developing treatment that use the patient's own bone marrow to treat these illnesses. Through adherence to the strictest professional standards, moral integrity and scientific excellence, BrainStorm hopes to create novel treatments that benefit patients.
BrainStorm's main technology, NurOwn™, was developed by expert neurologist Prof. Eldad Melamed, Head of the Neurology Department at the Rabin Medical Center and a member of the Scientific Committee of Michael J. Fox Foundation for Parkinson's Research, in collaboration with prominent expert cell biologist Dr. Daniel Offen, from the Felsenstein Medical Research Center of Tel-Aviv University.

This scientific team is one of the first to successfully demonstrate the physiological release of dopamine from differentiated bone marrow cells in vitro. Furthermore, research conducted by this team showed that cells implanted into the brains of animal models with Parkinsonian behavior showed significantly improved symptoms. BrainStorm intends to apply their technology to the development of innovative autologous cell therapeutic products for the treatment of neurological illnesses.

BrainStorm’s efforts are focused on the development of the technology from the laboratory to the clinic with the following objectives:

•  developing a cell differentiation process according to FDA guidelines
•  demonstrating safety and efficacy: first in animals, then in patients
•  setting up facilities to provide NurOwn™ products and services for   transplantation in patients